Jeuveau

(PrabotulinumtoxinA-xvfs)

Jeuveau

Drug updated on 11/14/2023

Dosage FormInjection (intramuscular: 100 units/vial)
Drug ClassMultiple
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.

Product Monograph / Prescribing Information

Document TitleYearSource
Jeuveau (prabotulinumtoxinA-xvfs) Prescribing Information.2020Evolus Inc., Newport Beach, CA

Systematic Reviews / Meta-Analyses

Document TitleYearSource
Botulinum toxin type A for facial wrinkles. 2021Cochrane Database of Systematic Reviews
PrabotulinumtoxinA-xvfs for the treatment of moderate-to-severe glabellar lines.2021Annals of Pharmacotherapy
Assessment report: Nuceiva. 2019EMA